<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00719017</url>
  </required_header>
  <id_info>
    <org_study_id>03/2007</org_study_id>
    <nct_id>NCT00719017</nct_id>
  </id_info>
  <brief_title>Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery</brief_title>
  <official_title>Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery: a Randomized Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Magna Graecia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Magna Graecia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent findings have suggested that laparoscopic surgery is safe and effective, as well as
      laparotomic one, for treating patients with early stage endometrial cancer (ESEC). Moreover,
      our long-term previous data have shown a trend in vaginal cuff recurrence in subjects who
      underwent laparoscopic approach to ESEC consisting of extrafascial hysterectomy, bilateral
      salpingo-oophorectomy, pelvic +/- para-aortic nodes dissections, regardless grading or
      lymphovascular space invasion.

      Based on these considerations, the aim of the current protocol-study will be to compare two
      different strategies for vaginal cuff recurrences prevention in patients affected by ESEC
      treated with laparoscopic surgery. In particular, upper vaginectomy followed by observation
      will be compared to post-operative brachytherapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women with ESEC scheduled for laparoscopic surgery will be enrolled and randomized in three
      arms [vaginectomy group (VG), brachytherapy group (BG), and control group (CG)]. All
      laparoscopic procedures will consist of total hysterectomy, bilateral salpingo-oophorectomy,
      peritoneal washing, systematic inspection of peritoneal cavity and biopsy of each suspect
      lesion, and pelvic (and eventual para-aortic) lymphadenectomy. In VG an upper vaginecomy will
      be added to standard laparoscopic procedures followed by observation, whereas BG will receive
      post-operative brachytherapy. CG will be treated with standard protocol for management of
      ESEC according to National Comprehensive Cancer Network (www.nccn.org).

      Safety and efficacy data will be recorded in each group for 24 months of follow-up.

      Data will be analyzed using the intention-to-treat principle and a P value of 0.05 or less
      will be considered significant.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2007</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal cuff recurrences</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative complications</measure>
    <time_frame>six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Loco-regional recurrence rate</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distant recurrence rate</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Early Stage Endometrial Cancer</condition>
  <arm_group>
    <arm_group_label>Vaginectomy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Upper vaginectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Brachytherapy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Post-operative brachytherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Upper vaginectomy</intervention_name>
    <description>Laparoscopic surgery with upper vaginectomy</description>
    <arm_group_label>Vaginectomy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Post-operative brachytherapy</intervention_name>
    <description>Laparoscopic surgery followed by brachytherapy</description>
    <arm_group_label>Brachytherapy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard procedures</intervention_name>
    <description>Laparoscopic surgery +/- brachytherapy +/- pelvic radiation</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Early stage endometrial cancer

        Exclusion Criteria:

          -  Other pre-malignancies and malignancies

          -  Major medical conditions

          -  Psychiatric disorders

          -  Current or past history of acute or chronic physical illness

          -  Premenstrual syndrome (PMS)

          -  Current or past (within 6 months from study enrolment) use of drugs influencing
             cognition, vigilance, and/or mood.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano Palomba, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics and Gynecology, University &quot;Magna Graecia&quot; of Catanzaro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fulvio Zullo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, University &quot;Magna Graecia&quot; of Catanzaro</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefano Palomba, MD</last_name>
    <phone>+39-0961.883234</phone>
    <email>stefanopalomba@tin.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>&quot;Pugliese&quot; Hospital</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingrid Tomaino, MD</last_name>
      <phone>+39 0961 883234</phone>
      <email>angela.falbo@libero.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Zullo F, Palomba S, Russo T, Falbo A, Costantino M, Tolino A, Zupi E, Tagliaferri P, Venuta S. A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: a focus on the quality of life. Am J Obstet Gynecol. 2005 Oct;193(4):1344-52.</citation>
    <PMID>16202724</PMID>
  </reference>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2008</study_first_submitted>
  <study_first_submitted_qc>July 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2008</study_first_posted>
  <last_update_submitted>April 5, 2013</last_update_submitted>
  <last_update_submitted_qc>April 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Magna Graecia</investigator_affiliation>
    <investigator_full_name>Stefano Palomba</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Brachytherapy</keyword>
  <keyword>Early stage edometrial cancer</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Recurrence</keyword>
  <keyword>Treatment</keyword>
  <keyword>Vaginectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

